google-site-verification=Z_uoRd0b3XdVdrmzeuBxwVnnTutVNUbWIMxE71rh0fU
25 September 2019

How to Trade on Pharmacies in Administration

A case study to illustrate the practical and legal difficulties of trading on a pharmacy. Andrew Lambros

A pharmacy going into administration or liquidation used to be unfathomable. However, with increased competition, franchise networks and significant reductions in the Pharmaceutical Benefits Scheme (PBS), this has become a reality.

More pharmacies are likely to become insolvent and when this occurs, it is important that practitioners (and pharmacists) understand the legal and practical steps that need to be addressed when dealing with the complex regulatory environment and the unique challenges of insolvency in the pharmacy sector.

Recently, Bennett & Philp Directors, Andrew Lambros and Maurice Hannan were involved in the sale of an insolvent group of pharmacies, The Country Wellness Pharmacy Group. As a result, a case study has been prepared and released in the Australian Restructuring and Insolvency Journal (ARITA), which was written by Andrew Lambros and Ian Currie and William Clement of BRI Ferrier (who were the administrators of that group).

It covers a range of topics including pharmacy-specific issues, practical difficulties in trading on, the special court applications required, the sale process of pharmacies in administration and the importance of understanding the industry.

 

 


Individual liability limited by a scheme approved under professional standards legislation (personal injury work exempted).

How to Trade on Pharmacies in Administration

A case study to illustrate the practical and legal difficulties of trading on a pharmacy.

>
>
>
>

Related Posts

05 December 2024 Publications

Simplifying Liquidation Involving Multiple Trusts – Have You Considered a Pooling Order?

Find out more
29 November 2024 Publications

‘Tis the Season for Cyber Security Reform

Find out more
06 September 2024 Publications

Notice of Conditions – Should You Consent to an Order under Clause 175 of the Poisons and Therapeutic Goods Regulation?

Find out more
>
>
>
>
>
>
>
>

Stay in the know

Get our latest news and publications delivered straight to your inbox

  • This field is for validation purposes and should be left unchanged.